Locations

Mercer Island, WA, USA · Seattle, WA, USA · University of Washington, Seattle, WA, USA

industry

Biotechnology · DeepTech

Size

11-50 employees

Stage

Series B

founded in

2019

Alt Pep is a biomedical startup focused on transforming the diagnosis and treatment of amyloid diseases, including Alzheimer’s and Parkinson’s. Their innovative platform utilizes custom-designed synthetic peptides to selectively target and neutralize toxic oligomers associated with these diseases, enabling early detection and intervention. With a strong emphasis on scientific research and development, Alt Pep aims to make significant breakthroughs that could impact over a billion people globally, positioning itself as a leader in the biotech space.

Something looks off?
Open jobs at AltPep

On-site & Remote